The incidence of symptomatic infection with influenza virus in the Netherlands 2011/2012 through 2016/2017, estimated using Bayesian evidence synthesis

Abstract Due to differences in the circulation of influenza viruses, distribution and antigenic drift of A subtypes and B lineages, and susceptibility to infection in the population, the incidence of symptomatic influenza infection can vary widely between seasons and age-groups. Our goal was to estimate the symptomatic infection incidence in the Netherlands for the six seasons 2011/2012 through 2016/2017, using Bayesian evidence synthesis methodology to combine season-specific sentinel surveillance data on influenza-like illness (ILI), virus detections in sampled ILI cases and data on healthcare-seeking behaviour. Estimated age-aggregated incidence was 6.5 per 1000 persons (95% uncertainty interval (UI): 4.7–9.0) for season 2011/2012, 36.7 (95% UI: 31.2–42.8) for 2012/2013, 9.1 (95% UI: 6.3–12.9) for 2013/2014, 41.1 (95% UI: 35.0–47.7) for 2014/2015, 39.4 (95% UI: 33.4–46.1) for 2015/2016 and 27.8 (95% UI: 22.7–33.7) for season 2016/2017. Incidence varied substantially between age-groups (highest for the age-group <5 years: 23 to 47/1000, but relatively low for 65+ years: 2 to 34/1000 over the six seasons). Integration of all relevant data sources within an evidence synthesis framework has allowed the estimation – with appropriately quantified uncertainty – of the incidence of symptomatic influenza virus infection. These estimates provide valuable insight into the variation in influenza epidemics across seasons, by virus subtype and lineage, and between age-groups.

[1]  M. van Boven,et al.  The impact of influenza vaccination on infection, hospitalisation and mortality in the Netherlands between 2003 and 2015. , 2019, Epidemics.

[2]  A. Gordon,et al.  The Burden of Influenza: a Complex Problem , 2018, Current Epidemiology Reports.

[3]  M. Jit,et al.  Estimating burden of influenza‐associated influenza‐like illness and severe acute respiratory infection at public healthcare facilities in Romania during the 2011/12‐2015/16 influenza seasons , 2017, Influenza and other respiratory viruses.

[4]  A. Larrauri,et al.  Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010‐2016 , 2017, Influenza and other respiratory viruses.

[5]  Y. Sun,et al.  Estimated incidence and number of outpatient visits for seasonal influenza in 2015–2016 in Beijing, China , 2017, Epidemiology and Infection.

[6]  Y. Moreno,et al.  Influenzanet: Citizens Among 10 Countries Collaborating to Monitor Influenza in Europe , 2017, JMIR public health and surveillance.

[7]  A. Meijer,et al.  Surveillance of influenza and other respiratory infections in the Netherlands: winter 2014/2015 , 2015 .

[8]  R. Pebody,et al.  Excess mortality among the elderly in European countries, December 2014 to February 2015. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  C. Reed,et al.  Estimating Influenza Disease Burden from Population-Based Surveillance Data in the United States , 2015, PloS one.

[10]  M. Kretzschmar,et al.  Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods , 2014, BMC Public Health.

[11]  M. Kretzschmar,et al.  An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands , 2013, Influenza and other respiratory viruses.

[12]  Mariëtte Hooiveld,et al.  Driving factors of influenza transmission in the Netherlands. , 2013, American journal of epidemiology.

[13]  K. Auranen,et al.  Estimating the burden of A(H1N1)pdm09 influenza in Finland during two seasons , 2013, Epidemiology and Infection.

[14]  W. John Edmunds,et al.  Assessing Optimal Target Populations for Influenza Vaccination Programmes: An Evidence Synthesis and Modelling Study , 2013, PLoS medicine.

[15]  M. Kretzschmar,et al.  Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. , 2012, The Journal of infectious diseases.

[16]  S. Khurana,et al.  Influenza Virus H1N1pdm09 Infections in the Young and Old: Evidence of Greater Antibody Diversity and Affinity for the Hemagglutinin Globular Head Domain (HA1 Domain) in the Elderly than in Young Adults and Children , 2012, Journal of Virology.

[17]  A Charlett,et al.  Changes in severity of 2009 pandemic A/H1N1 influenza in England: a Bayesian evidence synthesis , 2011, BMJ : British Medical Journal.

[18]  Paul A. Biedrzycki,et al.  The severity of pandemic H1N1 influenza in the United States, April – July 2009 , 2010, PLoS currents.

[19]  M. Lipsitch,et al.  The Severity of Pandemic H1N1 Influenza in the United States, from April to July 2009: A Bayesian Analysis , 2009, PLoS medicine.

[20]  S. V. van Noort,et al.  Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. , 2009, Vaccine.

[21]  A Flahault,et al.  Influenza vaccine: the challenge of antigenic drift. , 2007, Vaccine.

[22]  M. Kretzschmar,et al.  Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. , 2006, American journal of epidemiology.

[23]  A. Perelson,et al.  Kinetics of Influenza A Virus Infection in Humans , 2006, Journal of Virology.

[24]  E. D. Kilbourne.  Influenza Pandemics of the 20th Century , 2006, Emerging infectious diseases.

[25]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[26]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[27]  Bhupal Singh.  Influenza , 1916, Nature Reviews Disease Primers.

[28]  Surveillance of influenza and other respiratory infections. , 2000, Communicable disease report. CDR weekly.